metricas
covid
Endocrinología, Diabetes y Nutrición (English ed.) Cost-effectiveness evaluation of the use of PCSK9 inhibitors
Journal Information

Statistics

Follow this link to access the full text of the article

Editorial
Cost-effectiveness evaluation of the use of PCSK9 inhibitors
Evaluación del coste-efectividad de la utilización de los inhibidores de PCSK9
Fernando Civeiraa,
Corresponding author
civeira@unizar.es

Corresponding author.
, Juan Pedro-Botetb
a Hospital Universitario Miguel Servet, IIS Aragón, CIBERCV, Universidad de Zaragoza, Zaragoza, Spain
b Hospital Del Mar, Universitat Autònoma de Barcelona, Institut Hospital Del Mar D’Investigacions Mèdiques (IMIM), Barcelona, Spain
Read
2298
Times
was read the article
394
Total PDF
1904
Total HTML
Share statistics
Article information
ISSN: 25300180
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 45 15 60
2025 11 208 62 270
2025 10 123 21 144
2025 9 149 27 176
2025 8 139 29 168
2025 7 110 12 122
2025 6 91 5 96
2025 5 117 12 129
2025 4 46 4 50
2025 3 61 7 68
2025 2 38 7 45
2025 1 28 6 34
2024 12 24 4 28
2024 11 23 4 27
2024 10 19 6 25
2024 9 32 19 51
2024 8 21 13 34
2024 7 20 7 27
2024 6 26 13 39
2024 5 21 5 26
2024 4 20 1 21
2024 3 25 5 30
2024 2 29 2 31
2024 1 16 3 19
2023 12 9 2 11
2023 11 18 5 23
2023 10 23 3 26
2023 9 8 2 10
2023 8 11 1 12
2023 7 11 1 12
2023 6 33 3 36
2023 5 37 0 37
2023 4 39 0 39
2023 3 39 0 39
2023 2 26 2 28
2023 1 18 3 21
2022 12 10 2 12
2022 11 16 4 20
2022 10 11 4 15
2022 9 14 6 20
2022 8 6 8 14
2022 7 24 6 30
2022 6 21 4 25
2022 5 27 6 33
2022 4 18 14 32
2022 3 14 7 21
2022 2 9 8 17
2022 1 14 3 17
2021 12 14 9 23
2021 11 3 2 5
Show all

Follow this link to access the full text of the article